Covalon Technologies (OTCMKTS:CVALF) Stock Price Down 1.9%

Covalon Technologies Ltd. (OTCMKTS:CVALF)’s share price traded down 1.9% on Friday . The company traded as low as $0.80 and last traded at $0.80. 3,700 shares changed hands during mid-day trading, a decline of 32% from the average session volume of 5,413 shares. The stock had previously closed at $0.82.

Covalon Technologies Price Performance

The firm has a market cap of $20.06 million, a P/E ratio of -5.33 and a beta of -0.56. The business’s 50-day moving average is $0.87 and its two-hundred day moving average is $0.89.

Covalon Technologies (OTCMKTS:CVALF) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.02) EPS for the quarter. Covalon Technologies had a negative net margin of 19.70% and a negative return on equity of 23.88%. The firm had revenue of $3.43 million during the quarter.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.